•
Dec 31, 2023

Solid Biosciences Q4 2023 Earnings Report

Total Revenue
$4.74M
Previous year: $8.09M
-41.5%
EPS
-$1
Previous year: -$0.68
+47.1%
Gross Profit
$4.15M
Previous year: $7.56M
-45.1%
Cash and Equivalents
$124M
Previous year: $155M
-20.4%
Free Cash Flow
-$20.9M
Previous year: -$35.3M
-40.8%
Total Assets
$165M
Previous year: $260M
-36.6%

Solid Biosciences

Solid Biosciences